• Citer

Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS"

par Anastasilakis, Athanasios A.D.;Pepe, Jessica;Napoli, N.;Palermo, Andrea;Magopoulos, Christos;Khan, Aliya Aziz;Zillikens, Maria Carola Carola M.C.;Body, Jean-Jacques
Référence The Journal of clinical endocrinology and metabolism, 107, 6, page (E2651-E2652)
Publication Publié, 2022-06

Lettre à l'éditeur

• Accès en ligne
• Détails
• Statistiques

Titre:	Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS"
Auteur:	Anastasilakis, Athanasios A.D.; Pepe, Jessica; Napoli, N.; Palermo, Andrea; Magopoulos, Christos; Khan, Aliya Aziz; Zillikens, Maria Carola Carola M.C.; Body, Jean-Jacques
Informations sur la publication:	The Journal of clinical endocrinology and metabolism, 107, 6, page (E2651-E2652)
Statut de publication:	Publié, 2022-06
Sujet CREF:	Généralités
Mots-clés:	bisphosphonates
	bone metastases
	denosumab
	osteonecrosis of the jaw
	osteoporosis
Note générale:	SCOPUS: le.j
Langue:	Anglais
Identificateurs:	urn:issn:0021-972X
	info:doi/10.1210/clinem/dgac111
	info:scp/85130644876
	info:pmid/35213729